Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07066657
What this trial is testing

MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsColorectal CancerGastric Cancer+1 more
ArriVent BioPharma, Inc. 572
Early research (Phase 1)Looking for participantsNCT06440005
What this trial is testing

Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Who this might be right for
CancerAdvanced CancerLocally Advanced Carcinoma+8 more
Angiex, Inc. 80
Early research (Phase 1)Ended earlyNCT06599502
What this trial is testing

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
AstraZeneca 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827953
What this trial is testing

Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Nelum Corp 28
Testing effectiveness (Phase 2)Study completedNCT03861702
What this trial is testing

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Who this might be right for
Locally Advanced Pancreatic Carcinoma(LAPC)
Nelson Yee 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04986930
What this trial is testing

MFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer Non-resectable
Asan Medical Center 92
Testing effectiveness (Phase 2)Study completedNCT00609336
What this trial is testing

Perioperative Therapy for Resectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasStage IA Pancreatic CancerStage IB Pancreatic Cancer+2 more
University of Washington 35
Testing effectiveness (Phase 2)UnknownNCT05100329
What this trial is testing

Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 38
Large-scale testing (Phase 3)Study completedNCT00023972
What this trial is testing

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Daiichi Sankyo
Not applicableNot Yet RecruitingNCT05585554
What this trial is testing

Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy

Who this might be right for
Pancreatic Cancer
Viewray Inc. 267
Early research (Phase 1)Study completedNCT02154737
What this trial is testing

Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tony Reid, M.D., Ph.D. 24
Testing effectiveness (Phase 2)UnknownNCT00057395
What this trial is testing

A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies

Who this might be right for
Esophageal NeoplasmsHepatocellular CarcinomaColorectal Neoplasms+3 more
Aronex Pharmaceuticals 40
Not applicableAvailableNCT04566393
What this trial is testing

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

Who this might be right for
Pancreatic CancerSmall Bowel CancerColorectal Cancer+18 more
xCures
Early research (Phase 1)Study completedNCT04805307
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

Who this might be right for
Advanced Solid TumorGastric Cancer(Including Gastroesophageal Junction Adenocarcinoma)Pancreatic Cancer
Keymed Biosciences Co.Ltd 176
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Large-scale testing (Phase 3)Study completedNCT03941093
What this trial is testing

Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Kyntra Bio 284
Not applicableUnknownNCT05201729
What this trial is testing

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 30
Early research (Phase 1)Active Not RecruitingNCT05783622
What this trial is testing

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+4 more
Janux Therapeutics 130
Testing effectiveness (Phase 2)Study completedNCT05074472
What this trial is testing

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Who this might be right for
Solid Tumor, AdultPancreatic Ductal; AdenocarcinomaOvarian Serous Adenocarcinoma+2 more
ZielBio, Inc. 35
Testing effectiveness (Phase 2)Looking for participantsNCT06770439
What this trial is testing

IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancers
Zhejiang University 64
Next Page